Proposal For EMA To Provide Medtech Expert Panel Structure Gains Traction
Executive Summary
The medtech industry has long resisted having the European Medicines Agency involved in device oversight. Now an EU-level proposal is making device makers nervous.
You may also be interested in...
European Parliament Gives Final Go Ahead To EMA’s New Roles In Devices Oversight
The new EU regulation on increasing powers of the European Medicines Agency in future health crises applies as of 1 March; it controversially sees the agency become more involved in device oversight.
EU One Step Closer To Confirming EMA's New Pivotal Role In Device Matters
Industry opposes the proposed new role of European Medicines Agency in overseeing devices availability in a healthcare crisis. But a new Regulation may be adopted in March and its fallout looks set to herald a new era for device supply management and regulation.
Expert Panel Review Likely For Just 10% To 20% Of Files Submitted
Expert panel review of clinical files for high-risk devices is happening for the first time under the new EU medtech regulations. The process has begun but expert panel opinions may be rarer than many had originally expected.